Log in
OTCMKTS:PTIX

Protagenic Therapeutics Stock Forecast, Price & News

$1.22
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.22
Now: $1.22
$1.22
50-Day Range
$1.17
MA: $1.21
$2.00
52-Week Range
$0.16
Now: $1.22
$4.15
Volume1 shs
Average Volume375 shs
Market Capitalization$12.51 million
P/E RatioN/A
Dividend YieldN/A
Beta-4.04
Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.68 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PTIX
CUSIPN/A
Phone212-994-8200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.06) per share

Profitability

Net Income$-1,750,000.00

Miscellaneous

EmployeesN/A
Market Cap$12.51 million
Next Earnings Date9/30/2020 (Estimated)
OptionableNot Optionable
$1.22
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Protagenic Therapeutics (OTCMKTS:PTIX) Frequently Asked Questions

How has Protagenic Therapeutics' stock been impacted by Coronavirus?

Protagenic Therapeutics' stock was trading at $1.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PTIX shares have decreased by 28.2% and is now trading at $1.22.
View which stocks have been most impacted by COVID-19
.

When is Protagenic Therapeutics' next earnings date?

Protagenic Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020.
View our earnings forecast for Protagenic Therapeutics
.

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics Inc (OTCMKTS:PTIX) issued its quarterly earnings data on Tuesday, May, 15th. The biotechnology company reported ($0.06) earnings per share for the quarter.
View Protagenic Therapeutics' earnings history
.

Who are some of Protagenic Therapeutics' key competitors?

What other stocks do shareholders of Protagenic Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Protagenic Therapeutics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Processa Pharmaceuticals (PCSA), Acasti Pharma (ACST), Akero Therapeutics (AKRO), Athersys (ATHX), AVEO Pharmaceuticals (AVEO), CymaBay Therapeutics (CBAY), Cerecor (CERC) and Cumberland Pharmaceuticals (CPIX).

Who are Protagenic Therapeutics' key executives?

Protagenic Therapeutics' management team includes the following people:
  • Dr. Garo H. Armen, Co-Founder & Exec. Chairman (Age 66)
  • Dr. Alexander K. Arrow C.F.A., M.D., CFA, CFO, Compliance Officer & Sec. (Age 48)
  • Dr. Dalia Barsyte, Chief Technology Officer
  • Dr. David A. Lovejoy, Chief Scientific Officer

What is Protagenic Therapeutics' stock symbol?

Protagenic Therapeutics trades on the OTCMKTS under the ticker symbol "PTIX."

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Protagenic Therapeutics' stock price today?

One share of PTIX stock can currently be purchased for approximately $1.22.

How big of a company is Protagenic Therapeutics?

Protagenic Therapeutics has a market capitalization of $12.51 million.

What is Protagenic Therapeutics' official website?

The official website for Protagenic Therapeutics is www.protagenic.com.

How can I contact Protagenic Therapeutics?

Protagenic Therapeutics' mailing address is 149 FIFTH AVENUE SUITE 500, NEW YORK NY, 10010. The biotechnology company can be reached via phone at 212-994-8200 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.